Your browser doesn't support javascript.
loading
Performance of an artificial intelligence automated system for diabetic eye screening in a large English population.
Meredith, Sarah; van Grinsven, Mark; Engelberts, Jonne; Clarke, Dominic; Prior, Vicki; Vodrey, Jo; Hammond, Alison; Muhammed, Raja; Kirby, Philip.
Afiliación
  • Meredith S; InHealth Intelligence Ltd, Winsford, UK.
  • van Grinsven M; Thirona B.V., Nijmegen, The Netherlands.
  • Engelberts J; Thirona B.V., Nijmegen, The Netherlands.
  • Clarke D; InHealth Intelligence Ltd, Winsford, UK.
  • Prior V; InHealth Intelligence Ltd, Winsford, UK.
  • Vodrey J; InHealth Intelligence Ltd, Winsford, UK.
  • Hammond A; InHealth Intelligence Ltd, Winsford, UK.
  • Muhammed R; InHealth Intelligence Ltd, Winsford, UK.
  • Kirby P; InHealth Intelligence Ltd, Winsford, UK.
Diabet Med ; 40(6): e15055, 2023 06.
Article en En | MEDLINE | ID: mdl-36719266
ABSTRACT

AIMS:

A diabetic eye screening programme has huge value in reducing avoidable sight loss by identifying diabetic retinopathy at a stage when it can be treated. Artificial intelligence automated systems can be used for diabetic eye screening but are not employed in the national English Diabetic Eye Screening Programme. The aim was to report the performance of a commercially available deep-learning artificial intelligence software in a large English population.

METHODS:

9817 anonymised image sets from 10,000 consecutive diabetic eye screening episodes were presented to an artificial intelligence software. The sensitivity and specificity of the artificial intelligence system for detecting diabetic retinopathy were determined using the diabetic eye screening programme manual grade according to national protocols as the reference standard.

RESULTS:

For no diabetic retinopathy versus any diabetic retinopathy, the sensitivity of the artificial intelligence grading system was 69.7% and specificity 92.2%. The performance of the artificial intelligence system was superior for no or mild diabetic retinopathy versus significant or referrable diabetic retinopathy with a sensitivity of 95.4% and specificity of 92.0%. No cases were identified in which the artificial intelligence grade had missed significant diabetic retinopathy.

CONCLUSION:

The performance of a commercially available deep-learning artificial intelligence system for identifying diabetic retinopathy in an English national Diabetic Eye Screening Programme is presented. Using the pre-defined settings artificial intelligence performance was highest when identifying diabetic retinopathy which requires an action by the screening programme.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus / Retinopatía Diabética Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus / Retinopatía Diabética Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido